Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001387131-22-008886
Filing Date
2022-08-18
Accepted
2022-08-18 16:36:42
Documents
1
Period of Report
2022-08-16

Document Format Files

Seq Description Document Type Size
1 zangeneh-form4_081622.html 4  
1 zangeneh-form4_081622.xml 4 7170
  Complete submission text file 0001387131-22-008886.txt   8730
Mailing Address MAKY ZANGANEH & ASSOCIATES 51 ADAM WAY ATHERTON CA 94027
Business Address
Zanganeh Maky (Reporting) CIK: 0001507650 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36866 | Film No.: 221177848

Mailing Address 2882 SAND HILL ROAD SUITE 106 MENLO PARK CA 94025
Business Address 2882 SAND HILL ROAD SUITE 106 MENLO PARK CA 94025 617-514-7149
Summit Therapeutics Inc. (Issuer) CIK: 0001599298 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations